97 related articles for article (PubMed ID: 6145768)
21. Cardiovascular effects of intracerebroventricularly injected CDP-choline in normotensive and hypotensive animals: the involvement of cholinergic system.
Savci V; Cavun S; Goktalay G; Ulus IH
Naunyn Schmiedebergs Arch Pharmacol; 2002 May; 365(5):388-98. PubMed ID: 12012025
[TBL] [Abstract][Full Text] [Related]
22. Dopamine receptor agonists, N,N-dipropyl-2-aminotetralin (TL-68) and 2-di-n-propylamino-4,7-dimethoxyindane (RDS-127) antagonize oxotremorine-induced tremors by antimuscarinic action in mice.
Sahin I; Tuncer M; Ilhan M
Arch Int Physiol Biochim; 1990 Mar; 98(1):7-9. PubMed ID: 1692697
[TBL] [Abstract][Full Text] [Related]
23. Involvement of central dopamine receptors in the hypotensive action of pergolide.
Jadhav AL; Willett RN; Sapru HN; Lokhandwala MF
Naunyn Schmiedebergs Arch Pharmacol; 1983 Dec; 324(4):281-6. PubMed ID: 6664381
[TBL] [Abstract][Full Text] [Related]
24. Mechanisms underlying the cardiovascular responses to spinal dopamine receptor stimulation by apomorphine in anesthetized rats.
Lahlou S
Neurosci Lett; 2003 Jan; 335(3):187-91. PubMed ID: 12531464
[TBL] [Abstract][Full Text] [Related]
25. A comparison of the central and peripheral antimuscarinic effects of atropine and methylatropine injected systemically and into the cerebral ventricles.
Brezenoff HE; Xiao YF; Vargas H
Life Sci; 1988; 42(8):905-11. PubMed ID: 3343890
[TBL] [Abstract][Full Text] [Related]
26. Pharmacological, hemodynamic and autonomic nervous system mechanisms responsible for the blood pressure and heart rate lowering effects of pergolide in rats.
Cavero I; Lefevre-Borg F; Lhoste F; Sabatier C; Richer C; Giudicelli JF
J Pharmacol Exp Ther; 1984 Mar; 228(3):779-91. PubMed ID: 6707926
[TBL] [Abstract][Full Text] [Related]
27. Effects of prazosin and piperoxan on central cardiovascular actions of St 91 in cats.
McLennan PL; Bentley GA
Eur J Pharmacol; 1982 Dec; 86(1):19-26. PubMed ID: 7160431
[TBL] [Abstract][Full Text] [Related]
28. Cardiovascular and ventilatory effects of taurine and homotaurine in anaesthetized rats.
Paakkari P; Paakkari I; Karppanen H; Halmekoski J; Paasonen MK
Med Biol; 1982 Dec; 60(6):316-22. PubMed ID: 7162225
[TBL] [Abstract][Full Text] [Related]
29. Antinociception and cardiovascular responses produced by intravenous morphine: the role of vagal afferents.
Randich A; Thurston CL; Ludwig PS; Timmerman MR; Gebhart GF
Brain Res; 1991 Mar; 543(2):256-70. PubMed ID: 2059834
[TBL] [Abstract][Full Text] [Related]
30. Hypotensive action of 8-hydroxy-2-(di-N-propylamino)tetralin (8-OH-DPAT) in spontaneously hypertensive rats.
Martin GE; Lis EV
Arch Int Pharmacodyn Ther; 1985 Feb; 273(2):251-61. PubMed ID: 3159366
[TBL] [Abstract][Full Text] [Related]
31. Conformational analysis of 2-aminoindans and 2-(aminomethyl)indans in relation to their central dopaminergic effects and a dynamic dopamine receptor concept.
Wikström H; Lii JH; Allinger NL
J Med Chem; 1987 Jul; 30(7):1115-20. PubMed ID: 3599018
[TBL] [Abstract][Full Text] [Related]
32. Central cardiovascular effects of physostigmine in the cat; possible cholinergic aspects of blood pressure regulation.
de Wildt DJ; Porsius AJ
Arch Int Pharmacodyn Ther; 1981 Sep; 253(1):22-39. PubMed ID: 6119963
[TBL] [Abstract][Full Text] [Related]
33. Investigation on the cardiovascular effects of aprindine.
Mertens HM; Neuhaus KL
Acta Cardiol; 1974; Suppl 18():163-9. PubMed ID: 4547611
[No Abstract] [Full Text] [Related]
34. Effects of a potent dopamine receptor agonist, RDS-127, on penile reflexes and seminal emission in intact and spinally transected rats.
Stefanick ML; Smith ER; Clark JT; Davidson JM
Physiol Behav; 1982 Dec; 29(6):973-8. PubMed ID: 7163401
[TBL] [Abstract][Full Text] [Related]
35. Is domperidone a selective peripheral dopamine-receptor antagonist in vivo?
Arnerić SP; Collins ED; Bhatnagar RK; Long JP
Neuropharmacology; 1982 Dec; 21(12):1317-21. PubMed ID: 7155311
[TBL] [Abstract][Full Text] [Related]
36. The role of presynaptic receptors in the cardiovascular actions of N,N-di-n-propyldopamine in the cat and dog.
Massingham R; Dubocovich ML; Langer SZ
Naunyn Schmiedebergs Arch Pharmacol; 1980 Oct; 314(1):17-28. PubMed ID: 7442823
[TBL] [Abstract][Full Text] [Related]
37. A central site of dopamine agonist action to modify gastric secretion in the rat.
Costall B; Naylor RJ; Tan CC
Eur J Pharmacol; 1985 Oct; 117(1):61-9. PubMed ID: 2867911
[TBL] [Abstract][Full Text] [Related]
38. Central and peripheral dopaminergic mechanisms in the cardiovascular actions of pergolide in neurogenic hypertensive dogs.
Barrett RJ; Lokhandwala MF
Eur J Pharmacol; 1983 Dec; 96(3-4):211-26. PubMed ID: 6676105
[TBL] [Abstract][Full Text] [Related]
39. A comparison of the cardiovascular and sedative actions of the alpha-adrenoceptor agonists, FLA-136 and clonidine, in the rat.
Hamilton TC; Longman SD
Br J Pharmacol; 1982 Jan; 75(1):13-21. PubMed ID: 6122478
[TBL] [Abstract][Full Text] [Related]
40. Central benzodiazepine involvement in clonidine cardiovascular actions.
Castro JL; Ricci D; Taira CA; Ramirez A
Can J Physiol Pharmacol; 1999 Nov; 77(11):844-51. PubMed ID: 10593656
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
